Aussie Sirtex Liver Cancer Therapy To Be Tested Against Bayer Drug
This article was originally published in PharmAsia News
Executive Summary
Australia's Sirtex Medical and its SIR-Spheres for treating advanced liver cancer are about to be challenged in a Phase III study set up by a Singapore company